Scientists have discovered new links between the breakdown in brain cell development and the risk of schizophrenia and other psychiatric disorders.

A new study has found that people who experienced increased stress, anxiety and depression at the start of the pandemic, were at greater risk of getting COVID-19. The research found that greater psychological distress during the early phase of the pandemic was significantly associated with participants later reporting SARS-CoV-2 infection, a greater number of symptoms and also more severe symptoms.

Researchers have identified the effects of an environmental stressor, sleep deprivation, that could alter the balance controlled by antipsychotic drugs and impact individuals with schizophrenia.

Researchers have identified a biomarker in human platelets that tracks the extent of depression.

Scientists investigating the DNA outside our genes - the 'dark genome' - have discovered recently evolved regions that code for proteins associated with schizophrenia and bipolar disorder.

Scientists report that norepinephrine, a fundamental chemical for brain performance, is locally regulated in a brain region called the visual cortex.

Middle-aged women who practiced self-compassion had lower risk of developing cardiovascular disease, irrespective of their blood pressure, insulin resistance and cholesterol levels.

Use of assisted reproductive techniques (ART) does not lead to poorer mental health in children across adolescence and young adulthood, according to a large observational study. The study found a slightly higher risk of obsessive-compulsive disorder for those born after ART but this was explained by parental background factors.

Computer- and smartphone-based treatments appear to be effective in reducing symptoms of depression, and while it remains unclear whether they are as effective as face-to-face psychotherapy, they offer a promising alternative to address the growing mental health needs spawned by the COVID-19 pandemic, according to new research.

Neuroscientists have discovered a set of brain cells that influence the motivation of mice to perform tasks for rewards. Increasing the cells' activity makes a mouse work harder or more vigorously. The neurons come with a feature that prevents the mouse from overdoing it and becoming addicted to the reward. The findings reveal new possible therapeutic strategies for treating mental illnesses like depression that impair motivation.